Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway.

Ulusan M, Erdogan MA, Simsek O, Dogan Z, Ciftci BB, Atalan G, Erbas O

Open source

DOI
10.3390/medicina61050857
Published
2025 May 6
Container
Medicina (Kaunas, Lithuania)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina61050857,
  title = {Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway.},
  author = {Ulusan M and Erdogan MA and Simsek O and Dogan Z and Ciftci BB and Atalan G and Erbas O},
  year = {2025},
  journal = {Medicina (Kaunas, Lithuania)},
  doi = {10.3390/medicina61050857},
  url = {https://doi.org/10.3390/medicina61050857}
}

RIS

TY  - JOUR
TI  - Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway.
AU  - Ulusan M
AU  - Erdogan MA
AU  - Simsek O
AU  - Dogan Z
AU  - Ciftci BB
AU  - Atalan G
AU  - Erbas O
PY  - 2025
JO  - Medicina (Kaunas, Lithuania)
DO  - 10.3390/medicina61050857
UR  - https://doi.org/10.3390/medicina61050857
ER  - 

APA

M, U., MA, E., O, S., Z, D., BB, C., G, A., & O, E. (2025). Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina61050857

Source records